June 28 (Reuters) - Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS INC - WILL REDUCE ITS WORKFORCE BY 17
PEOPLE,
OR APPROXIMATELY 43% OF COMPANY'S EXISTING HEADCOUNT
* OVID THERAPEUTICS INC - EXPECTS THAT EXECUTION OF
WORKFORCE
REDUCTION WILL BE SUBSTANTIALLY COMPLETE BY END OF Q3 OF 2024
* OVID THERAPEUTICS INC - MAJORITY OF CASH PAYMENTS RELATED
TO
RESTRUCTURING WILL BE SUBSTANTIALLY COMPLETE BY END OF Q2 2025.
* OVID THERAPEUTICS INC - ANTICIPATES A ONE-TIME
SEVERANCE-RELATED
CHARGE ASSOCIATED WITH WORKFORCE REDUCTION TO BE APPROXIMATELY
$4.0 MILLION
* OVID THERAPEUTICS - BELIEVES THAT ITS CASH RUNWAY WILL BE
SUFFICIENT TO FUND ITS OPERATIONS INTO THE FIRST HALF OF 2026
Source text for Eikon: ID:n0001193125-24-172225
Further company coverage: OVID.O
((reuters.briefs@thomsonreuters.com;))